News
After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...
FOX 32 Chicago on MSN3d
New weight-loss drug shows promiseWeight loss drugs like Ozempic, Zepbound and Wegovy are surging in popularity. Now, a new pill from Eli Lilly has taken a ...
The first GLP-1 weight-loss pill is a step closer to hitting the market. Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes patients lower blood sugar—and ...
(Bloomberg) -- Eli Lilly & Co. shares surged after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already ...
after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form. The last time the stock rose as much was June 29 ...
glucose control and weight loss, and we look forward to additional data readouts later this year." "As a convenient once-daily pill, Orforglipron may provide a new option and, if approved ...
A once-daily weight loss pill in late-stage trials is showing promising results. The oral GLP-1 drug from Eli Lilly is in phase three of clinical studies to determine safety and efficacy for ...
Smaller biotechnology companies, and large pharmaceutical rivals including AstraZeneca Plc, are still working on their own weight-loss pills, with varying degrees of success. Lilly, which was ...
The pill, poised to revolutionize the weight loss world, may be up for FDA approval in late 2025. A daily pill to rival Ozempic is one step closer to hitting the market. Pharmaceutical giant Eli ...
Orforglibron, a pill form of GLP-1 weight loss injections like Ozempic and Mounjaro, is undergoing clinical trials. Drugmaker Eli Lilly said the first trial showed similar weight loss and diabetes ...
A DAILY weight loss pill that works like Ozempic has succeeded in a major clinical trial. Patients lost an average of a stone and two pounds (7.3kg) each over 10 months. Unhealthy blood sugar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results